This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2019
Title: Zhiyong Li: Innovator in Hypolipidemic and Hypoglycemic Solutions
Introduction
Zhiyong Li, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of medicine through his innovative research. He holds a notable patent that addresses important health issues such as blood glucose and triglyceride levels.
Latest Patents
Zhiyong Li is recognized for his patent titled "Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein." This invention presents a groundbreaking application of Metrnl protein in the creation of a hypolipidemic and hypoglycemic medicine or dietary supplement. In addition to this, the patent also outlines a method for producing a mouse that has fat-specific overexpression of Metrnl, an important advancement for research in metabolic diseases.
Career Highlights
Throughout his career, Zhiyong Li has demonstrated a commitment to improving health through innovative solutions. His work in the development of therapeutic approaches using Metrnl protein showcases his expertise in medical research and dedication to enhancing human health. Li's contributions continue to have a positive impact on the scientific community and the treatment of metabolic disorders.
Collaborations
Zhiyong Li has collaborated with notable coworkers Chaoyu Miao and Pei Wang. Together, these innovators work towards advancing research in metabolic health and exploring the potential of Metrnl protein in medicine. Their combined efforts reflect a strong commitment to scientific collaboration and innovation.
Conclusion
Zhiyong Li's invention and ongoing contributions in the field of medicine exemplify the power of innovation in addressing critical health challenges. Through his patent, he has opened new avenues for research and development in treating issues related to blood glucose and triglyceride levels. As he continues to work alongside talented researchers, his future endeavors promise to further enhance our understanding of metabolic health and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile